Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by Spectracleson Apr 12, 2021 1:48pm
124 Views
Post# 32978336

RE:60 Minutes ; - ) "EUA" is one thing FDA "Expanded Use"...

RE:60 Minutes ; - ) "EUA" is one thing FDA "Expanded Use"...I wish it was our cartridge and not ExThera's being used but recognition of the style of blood purification is better than nothing. On ExThera's April 17, 2020 conditional FDA approval section I (3) states: "There is no adequate, approved, and available alternative to the emergency use of the Seraph 100 Microbind Affinity Blood Filter device for the treatment of these COVID-19 patients." No mention of Spectral which seems odd considering ours was also conditionally approved April 14th.
<< Previous
Bullboard Posts
Next >>